Findings

What do systematic reviews say?

22 questions · 22 findings · 3 reviews

No studies found 1 · 4.5%GRADE not reported 1 · 4.5%Very low 2 · 9.1%Low 9 · 40.9%Moderate 6 · 27.3%High 3 · 13.6%

Withdrawals due to adverse events · adults with Raynaud's phenomenon (primary or secondary)

1 finding from 1 review

Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate

Serious adverse events · adults with Raynaud's phenomenon (primary or secondary)

1 finding from 1 review

Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate